Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

383.12
-3.9900-1.03%
Post-market: 383.600.4800+0.13%19:59 EDT
Volume:3.39M
Turnover:1.31B
Market Cap:98.23B
PE:27.23
High:389.46
Open:388.60
Low:382.60
Close:387.11
52wk High:519.88
52wk Low:362.50
Shares:256.39M
Float Shares:255.58M
Volume Ratio:2.09
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.07
EPS(LYR):-2.0768
ROE:22.77%
ROA:13.09%
PB:5.72
PE(LYR):-184.48

Loading ...

Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
May 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Correspondence

Form CORRESP - Correspondence
May 05, 2025

Major Issues Report

Form 8-K - Current report
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities